Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 93.7% in August

Key Points

• Bayer Aktiengesellschaft experienced a significant increase in short interest, rising by 93.7% to a total of 232,000 shares as of August 15th.
• The company's stock saw a price increase of 2.7%, bringing it to $8.33, with a market cap of $32.73 billion.
• Bayer's latest quarterly earnings report surpassed expectations, with $0.35 EPS compared to the consensus of $0.25, and revenue of $12.42 billion against an expected $10.79 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 15th, there was short interest totaling 232,000 shares, agrowthof93.7% from the July 31st total of 119,800 shares. Based on an average daily trading volume, of 2,551,200 shares, the short-interest ratio is currently 0.1 days. Based on an average daily trading volume, of 2,551,200 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analyst Weigh In

BAYRY has been the subject of several research reports. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, August 19th. Kepler Capital Markets raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research note on Wednesday, June 11th. Zacks Research cut shares of Bayer Aktiengesellschaft from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 1st. Hsbc Global Res raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, June 11th. Finally, The Goldman Sachs Group raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Bayer Aktiengesellschaft currently has an average rating of "Buy".

Bayer Aktiengesellschaft Stock Performance

Bayer Aktiengesellschaft stock traded down $0.09 during mid-day trading on Friday, hitting $8.24. 659,540 shares of the company's stock traded hands, compared to its average volume of 625,951. The firm has a 50 day simple moving average of $7.99 and a two-hundred day simple moving average of $7.09. Bayer Aktiengesellschaft has a fifty-two week low of $4.79 and a fifty-two week high of $8.65. The stock has a market cap of $32.38 billion, a price-to-earnings ratio of -8.49, a P/E/G ratio of 3.76 and a beta of 0.93. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.13 and a quick ratio of 0.73.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.10. Bayer Aktiengesellschaft had a positive return on equity of 15.44% and a negative net margin of 7.61%.The company had revenue of $12.42 billion during the quarter, compared to the consensus estimate of $10.79 billion. On average, research analysts expect that Bayer Aktiengesellschaft will post 1.31 EPS for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.